FDA updates authorization of BioNTech, Pfizer's bivalent booster for young childrenMarket Watch • 03/15/23
BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023GlobeNewsWire • 03/13/23
Wall Street Thinks These 2 Undervalued Stocks Have Exceptional Growth PotentialThe Motley Fool • 03/10/23
Roquefort develops a fifth programme using a technology pioneer by Moderna and BioNTechProactive Investors • 03/08/23
BioNTech Announces Establishment of Interdisciplinary mRNA Excellence Center to Conduct Research Jointly with Scientists from Weizmann Institute of Science in IsraelGlobeNewsWire • 03/01/23
BioNTech on the verge of UK trials of cancer vaccine - here's our two-minute guideProactive Investors • 02/20/23
BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing FacilityGlobeNewsWire • 02/02/23
BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and DevelopmentGlobeNewsWire • 01/10/23
BioNTech cancer treatments deal is a coup for the government and a challenge for the NHSSkynews • 01/06/23
Cancer Vaccine Trials—Using Same mRNA Tech Behind Covid Shots—Could Launch In U.K. This SeptemberForbes • 01/06/23
UK government inks landmark deal with BioNTech to create cancer vaccineProactive Investors • 01/06/23
BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030GlobeNewsWire • 01/06/23